The baricitinib experience –a full review of Olumiant in RA

0 SAR
Checkout

Overview

Watch an animated video on the baricitinib experience, a review of Olumiant in RA conducted by Prof. Taylor with key outcomes from all RCTs and RWE.

This Class for

  • Physician
  • Resident / Fellow

What I will learn?

  • The animation video includes voice over and provides a more visual and engaging way of presenting the findings of the review. The animations make the data come to life and support the story told by the voice over artist.




    Disclaimer

    This content is approved by Eli Lilly and Company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly's prior permission
    (This information/content is intended to Health Care Providers only)

    For adverse events and safety reporting: email: saudi_pharmacovigilance@lilly.com
    24 /7 mobile : +966 567 868 843 working hours: +966 11 461 7800 , Ext: 1
    For Lilly product information: email: SAUDI_MEDINFOQUERIES@lilly.com
    For further information, please contact:
    Eli Lilly and Company, Scientific Office P.O. Box 92120 Riyadh 11653, Kingdom of Saudi Arabia. Tel: +966 11 461 7800 Fax: +966 111 217 9900 email: Saudi_Pharmacovigilance@lilly.com

    Please go to PDF Material for prescribing information


    PP-BA-SA-1187

Related Classes